header image

The Latest in Early Detection for Pancreatic Cancer Webinar


PanCAN President and CEO Julie Fleshman, JD, MBA, welcomes a panel of pancreatic cancer experts for an hour-long question-and-answer session discussing:

  • • The latest efforts to detect pancreatic cancer

  • • Pancreatic cancer risk factors, including genetic factors and clinical indications

  • • Novel blood tests

  • • PanCAN’s investment in early detection and the launch of the Early Detection Initiative

  • • And much more!



card image

Julie M. Fleshman, JD, MBA,

PanCAN President and CEO, leading the way for more than two decades in PanCAN’s approach to take bold steps to make progress in pancreatic cancer research and improve patient outcomes

card image

Lynn Matrisian, PhD, MBA

PanCAN Chief Science Officer, bringing extensive cancer research experience and business training to provide strategic direction for the scientific aspects of PanCAN’s clinical and research initiatives

card image

Rosalie Sears, PhD

Co-Director, Brenden-Colson Center for Pancreatic Care, Knight Cancer Institute Oregon Health & Science University, Professor, Dept. of Molecular and Medical Genetics Krista L. Lake Chair in Cancer Research

card image

Brian M. Wolpin, MD, MPH

Chief, Division of Gastrointestinal Oncology, Dana-Farber Cancer Institute, Robert T. & Judith B. Hale Chair in Pancreatic Cancer, Dana-Farber Cancer Institute, Associate Professor of Medicine, Harvard Medical School


Thank you to our Scientific & Medical Affairs Industry Members

sponsor logo block

Contact our Patient Services team

for answers to any questions you have about pancreatic cancer, treatment options and more. Our expert case managers are here from 7 a.m. to 5 p.m. PT, Monday through Friday, to help. Contact us at 877-573-9971 or via our contact form.